Article By:
NASDAQ GlobeNewswire
Monday, October 26, 2020 10:44 AM EDT
Turning Point Therapeutics, Inc., today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell $400,000,000 of shares of its common stock.
In this article: TPTX